世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040446

次世代薬物複合体の世界市場レポート(2024年)

The Business Research Company

Next Generation Drug Conjugates Global Market Report 2024

発刊日 2024/12/09

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000040446

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、次世代薬物複合体の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている次世代薬物複合体市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 次世代薬剤複合体タイプ別
      ◇ ペプチド受容体放射性核種療法
      ◇ リガンド媒介RNAIコンジュゲート
      ◇ リガンド結合抗センス薬
      ◇ ペプチド薬剤複合体
    ➣ リガンドタイプ別
      ◇ アミノシュガー
      ◇ 脂質
      ◇ ペプチド
      ◇ 小分子
      ◇ ウイルスのような粒子
    ➣ ペイロードタイプ別
      ◇ オリゴヌクレオチド
      ◇ 放射性核種
      ◇ ペプチド
      ◇ 小分子
    ➣ 療法別
      ◇ 単独療法
      ◇ 併用療法
    ➣ 適応症別
      ◇ 消化管膵神経内分泌腫瘍
      ◇ 前立腺がん
      ◇ 乳がんの脳転移によって引き起こされる軟膜がん腫症
      ◇ 遺伝性トランスサイレチンアミロイドーシス
      ◇ 動脈硬化性心血管疾患
      ◇ 重度の高トリグリセリド血症
      ◇ 遺伝性血管性浮腫
      ◇ 急性肝性ポルフィリン症
      ◇ その他
  • 調査企業
    ➣ Pfizer Inc.
    ➣ Johnson & Johnson
    ➣ Merck & Co. Inc.
    ➣ AbbVie Inc.
    ➣ Novartis International AG
  • 調査国
    オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Next Generation Drug Conjugates Market Characteristics

3. Next Generation Drug Conjugates Market Trends And Strategies

4. Next Generation Drug Conjugates Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Next Generation Drug Conjugates Market Size and Growth
5.1. Global Next Generation Drug Conjugates Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Next Generation Drug Conjugates Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Next Generation Drug Conjugates Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Next Generation Drug Conjugates Market Segmentation
6.1. Global Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Peptide Receptor Radionuclide Therapy
Ligand Mediated RNAI Conjugate
Ligand Conjugated Anti Sense Medicine
Peptide Drug Conjugate
6.2. Global Next Generation Drug Conjugates Market, Segmentation By Targeting Ligand Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Amino Sugar
Lipid
Peptide
Small Molecule
Virus-Like Particles
6.3. Global Next Generation Drug Conjugates Market, Segmentation By Payload Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oligonucleotide
Radionuclide
Peptide
Small Molecule
6.4. Global Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Monotherapy
Combination Therapy
6.5. Global Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Gastroenteropancreatic Neuroendocrine Tumors
Prostate Cancer
Leptomeningeal Carcinomatosis Caused By Breast Cancer Brain Metastases
Hereditary Transthyretin Amyloidosis
Atherosclerotic Cardiovascular Diseases
Severe Hypertriglyceridemia
Hereditary Angioedema
Acute Hepatic Porphyria
Other Indications

7. Next Generation Drug Conjugates Market Regional And Country Analysis
7.1. Global Next Generation Drug Conjugates Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Next Generation Drug Conjugates Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Next Generation Drug Conjugates Market
8.1. Asia-Pacific Next Generation Drug Conjugates Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Next Generation Drug Conjugates Market
9.1. China Next Generation Drug Conjugates Market Overview
9.2. China Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Next Generation Drug Conjugates Market
10.1. India Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Next Generation Drug Conjugates Market
11.1. Japan Next Generation Drug Conjugates Market Overview
11.2. Japan Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Next Generation Drug Conjugates Market
12.1. Australia Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Next Generation Drug Conjugates Market
13.1. Indonesia Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Next Generation Drug Conjugates Market
14.1. South Korea Next Generation Drug Conjugates Market Overview
14.2. South Korea Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Next Generation Drug Conjugates Market
15.1. Western Europe Next Generation Drug Conjugates Market Overview
15.2. Western Europe Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Next Generation Drug Conjugates Market
16.1. UK Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Next Generation Drug Conjugates Market
17.1. Germany Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Next Generation Drug Conjugates Market
18.1. France Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Next Generation Drug Conjugates Market
19.1. Italy Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Next Generation Drug Conjugates Market
20.1. Spain Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Next Generation Drug Conjugates Market
21.1. Eastern Europe Next Generation Drug Conjugates Market Overview
21.2. Eastern Europe Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Next Generation Drug Conjugates Market
22.1. Russia Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Next Generation Drug Conjugates Market
23.1. North America Next Generation Drug Conjugates Market Overview
23.2. North America Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Next Generation Drug Conjugates Market
24.1. USA Next Generation Drug Conjugates Market Overview
24.2. USA Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Next Generation Drug Conjugates Market
25.1. Canada Next Generation Drug Conjugates Market Overview
25.2. Canada Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Next Generation Drug Conjugates Market
26.1. South America Next Generation Drug Conjugates Market Overview
26.2. South America Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Next Generation Drug Conjugates Market
27.1. Brazil Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Next Generation Drug Conjugates Market
28.1. Middle East Next Generation Drug Conjugates Market Overview
28.2. Middle East Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Next Generation Drug Conjugates Market
29.1. Africa Next Generation Drug Conjugates Market Overview
29.2. Africa Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Next Generation Drug Conjugates Market Competitive Landscape And Company Profiles
30.1. Next Generation Drug Conjugates Market Competitive Landscape
30.2. Next Generation Drug Conjugates Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merck & Co. Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AbbVie Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Novartis International AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Next Generation Drug Conjugates Market Other Major And Innovative Companies
31.1. AstraZeneca PLC
31.2. Daiichi Sankyo Company Limited
31.3. Eisai Co Ltd.
31.4. Bicycle Therapeutics plc
31.5. Zymeworks Inc.
31.6. Genentech Inc.
31.7. MacroGenics Inc.
31.8. Abzena plc
31.9. Innate Pharma S.A.
31.10. CytomX Therapeutics Inc.
31.11. ImmunoGen Inc.
31.12. Ascentage Pharma Group International
31.13. Mersana Therapeutics Inc.
31.14. Antengene Corporation Limited
31.15. Nurix Therapeutics Inc.

32. Global Next Generation Drug Conjugates Market Competitive Benchmarking

33. Global Next Generation Drug Conjugates Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Next Generation Drug Conjugates Market

35. Next Generation Drug Conjugates Market Future Outlook and Potential Analysis
35.1 Next Generation Drug Conjugates Market In 2028 - Countries Offering Most New Opportunities
35.2 Next Generation Drug Conjugates Market In 2028 - Segments Offering Most New Opportunities
35.3 Next Generation Drug Conjugates Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Next Generation Drug Conjugates Market, Segmentation By Targeting Ligand Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Next Generation Drug Conjugates Market, Segmentation By Payload Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 7: Global Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 8: Global Next Generation Drug Conjugates Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 9: Global Next Generation Drug Conjugates Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 10: Asia-Pacific, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 11: Asia-Pacific, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 12: Asia-Pacific, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 13: China, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 14: China, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 15: China, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 16: India, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 17: India, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 18: India, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 19: Japan, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 20: Japan, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 21: Japan, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 22: Australia, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 23: Australia, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 24: Australia, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 25: Indonesia, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 26: Indonesia, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 27: Indonesia, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 28: South Korea, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 29: South Korea, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 30: South Korea, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 31: Western Europe, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 32: Western Europe, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 33: Western Europe, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 34: UK, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 35: UK, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 36: UK, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 37: Germany, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 38: Germany, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 39: Germany, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 40: France, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 41: France, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 42: France, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 43: Italy, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 44: Italy, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 45: Italy, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 46: Spain, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 47: Spain, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 48: Spain, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 49: Eastern Europe, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 50: Eastern Europe, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 51: Eastern Europe, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 52: Russia, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 53: Russia, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 54: Russia, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 55: North America, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 56: North America, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 57: North America, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 58: USA, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 59: USA, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 60: USA, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 61: Canada, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 62: Canada, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 63: Canada, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 64: South America, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 65: South America, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 66: South America, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 67: Brazil, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 68: Brazil, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 69: Brazil, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 70: Middle East, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 71: Middle East, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 72: Middle East, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 73: Africa, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Africa, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 75: Africa, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 76: Pfizer Inc. Financial Performance
Table 77: Johnson & Johnson Financial Performance
Table 78: Merck & Co. Inc. Financial Performance
Table 79: AbbVie Inc. Financial Performance
Table 80: Novartis International AG Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Figure 3: Global Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 4: Global Next Generation Drug Conjugates Market, Segmentation By Targeting Ligand Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 5: Global Next Generation Drug Conjugates Market, Segmentation By Payload Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 6: Global Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 7: Global Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 8: Global Next Generation Drug Conjugates Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 9: Global Next Generation Drug Conjugates Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 10: Asia-Pacific, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 11: Asia-Pacific, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 12: Asia-Pacific, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 13: China, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 14: China, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 15: China, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 16: India, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 17: India, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 18: India, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 19: Japan, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 20: Japan, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 21: Japan, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 22: Australia, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 23: Australia, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 24: Australia, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 25: Indonesia, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 26: Indonesia, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 27: Indonesia, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 28: South Korea, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 29: South Korea, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 30: South Korea, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 31: Western Europe, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 32: Western Europe, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 33: Western Europe, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 34: UK, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 35: UK, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 36: UK, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 37: Germany, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 38: Germany, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 39: Germany, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 40: France, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 41: France, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 42: France, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 43: Italy, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 44: Italy, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 45: Italy, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 46: Spain, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 47: Spain, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 48: Spain, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 49: Eastern Europe, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 50: Eastern Europe, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 51: Eastern Europe, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 52: Russia, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 53: Russia, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 54: Russia, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 55: North America, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 56: North America, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 57: North America, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 58: USA, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 59: USA, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 60: USA, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 61: Canada, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 62: Canada, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 63: Canada, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 64: South America, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 65: South America, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 66: South America, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 67: Brazil, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 68: Brazil, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 69: Brazil, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 70: Middle East, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 71: Middle East, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 72: Middle East, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 73: Africa, Next Generation Drug Conjugates Market, Segmentation By Next-Generation Drug Conjugates Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 74: Africa, Next Generation Drug Conjugates Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 75: Africa, Next Generation Drug Conjugates Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 76: Pfizer Inc. Financial Performance
Figure 77: Johnson & Johnson Financial Performance
Figure 78: Merck & Co. Inc. Financial Performance
Figure 79: AbbVie Inc. Financial Performance
Figure 80: Novartis International AG Financial Performance

この商品のレポートナンバー

0000040446

TOP